WDR81 Gene Mental Retardation with Cerebellar Ataxia and Dysequilibrium Syndrome Type 2 Genetic Test
Test Name: WDR81 Gene Mental retardation with Cerebellar ataxia and dysequilibrium syndrome type 2 Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test type: Neurological Disorders
Doctor: Neurologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for WDR81 Gene Mental retardation with Cerebellar ataxia and dysequilibrium syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with WDR81 Gene Mental retardation with Cerebellar ataxia and dysequilibrium syndrome type 2.
Test Details:
The WDR81 gene is associated with a rare genetic disorder called Mental Retardation with Cerebellar Ataxia and Dysequilibrium Syndrome Type 2 (CAMRQ2). This disorder is characterized by intellectual disability, developmental delay, cerebellar ataxia (problems with coordination and balance), and dysequilibrium (unsteady gait).
NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technology to analyze multiple genes simultaneously. In the context of CAMRQ2, NGS genetic testing can be used to identify mutations or variations in the WDR81 gene that may be causing the disorder. By analyzing the WDR81 gene, NGS genetic testing can provide information about the specific genetic variant responsible for CAMRQ2. This information can help with the diagnosis of the disorder, as well as provide important insights into its underlying cause and potential treatment options.
| Test Name | WDR81 Gene Mental retardation with Cerebellar ataxia and dysequilibrium syndrome type 2 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for WDR81 Gene Mental retardation with Cerebellar ataxia and dysequilibrium syndrome type 2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with WDR81 Gene Mental retardation with Cerebellar ataxia and dysequilibrium syndrome type 2 |
| Test Details | The WDR81 gene is associated with a rare genetic disorder called Mental Retardation with Cerebellar Ataxia and Dysequilibrium Syndrome Type 2 (CAMRQ2). This disorder is characterized by intellectual disability, developmental delay, cerebellar ataxia (problems with coordination and balance), and dysequilibrium (unsteady gait). NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technology to analyze multiple genes simultaneously. In the context of CAMRQ2, NGS genetic testing can be used to identify mutations or variations in the WDR81 gene that may be causing the disorder. By analyzing the WDR81 gene, NGS genetic testing can provide information about the specific genetic variant responsible for CAMRQ2. This information can help with the diagnosis of the disorder, as well as provide important insights into its underlying cause and potential treatment options. |
